Fundz

Kazia Therapeutics Limited announces a public offering priced at up to $120 million, aiming to raise approximately $40 million from the sale of securities. The offering includes American Depositary Shares and warrants.

PUBLIC · KZIAAug 28, 2026

Amount Raised

$40 Million

Round Type

Post-IPO Equity

SydneyBiotechnologyHealth Care

Description

Kazia Therapeutics Limited, an oncology-focused biotechnology company, has announced a priced public offering. The offering includes American Depositary Shares and Series A and B Warrants. The expected gross proceeds from the sale are approximately $40 million. These funds will be used to support its ongoing development of cancer therapies.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Kazia Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Mentara Therapeutics raised an undisclosed amount on October 12, 2026.
  • Sharp Biomedical raised an undisclosed amount (Pre-Seed) on October 12, 2026.
  • Scarlet raised $50M (Series B) on October 12, 2026.
  • B-Arm Medical Technologies raised $496K (Pre-Series A) on October 10, 2026.
  • SpectaCell raised $6.7M (Seed) on October 9, 2026.
  • Sava Technologies raised $36M (Series B) on October 9, 2026.

Who to call at Kazia Therapeutics, and when

A new round usually means Kazia Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kazia Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kazia Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kazia Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kazia Therapeutics

Location

Level 24, Three International Towers

Sydney, New South Wales, Australia

About

Kazia Therapeutics is a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need. The company focuses on innovative drug development and is based in Sydney, Australia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kazia Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMichael F., Program Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Kazia Therapeutics's next move

See what Strategic adds

Kazia Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.